Your SlideShare is downloading. ×
Case control studies..skp
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.


Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Case control studies..skp


Published on

Published in: Health & Medicine, Business

1 Like
  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. DR. Sudhira Kumar Parida.
  • 2. OVERVIEW Introduction. Design of a Case-Control Study. Hallmark. Selection of cases. Selection of controls. Problems in control selection. Multiple control. Matching. When warranted? Case-Control Study based in a defined cohort. Measurement of exposure. Analysis & Interpretation. Bias Adv & disadv. Examples
  • 3. INTRODUCTION Epidemiological Studies Observational studies  Experimental studiesA.Descriptive studies A.RCT/ Clinical trialsB.Analytical studies B.Field trials/ Community 1.Ecological/ intervention studies Correlational C.Community trials. 2.Cross-sectional/ Prevalence 3.Case-control/ Case- reference 4.Cohort/ Follow-up
  • 4. DESIGN OF A CASE-CONTROLSTUDY First Select CASES CONTROLS (with disease) (without ds)THEN MEASURE PAST EXPOSURE Were Exposed a b Were Not exposed c d Total a+c b+d Proportions Exposed a b a+c b+d
  • 5. HALLMARK It begins with people with the disease(CASES) & COMPARES them to people without the ds(CONTROLS).
  • 6. SELECTION OF CASES Definition of a CASE: i)diagnostic criteria & stage of the ds ,if any. ii)eligibility criteria-preferably incident cases. Sources: 2.population-based Case verification Exclusion criteria
  • 7. SELECTION OF CONTROLS Who is a CONTROL i)school rosters ii)selective service lists iii)insurance company lists iv)neighbourhood v)best friend vi)spouse/ sibling vii)dead
  • 8. USE OF MULTIPLE CONTROLS Same types: -increases the power of the study(only upto 1case:4control) Different types: -for exploring alternate hypotheses -for taking account possible potential biases like recall bias.
  • 9. MATCHING Def: The process of selecting the controls so that they are similar to cases in certain characteristics ,such as age,race,sex,socio-eco. status & occupation. Types: 1.Group/ Frequency 2.Individual/ Matched pairs. Problems: a)practical-difficulty in finding a control b)conceptual-cannot study that characteristic c)unplanned matching d)overmatching
  • 10. WHEN A CASE-CONTROL STUDYIS WARRANTED Often the 1st step in determining whether an exposure is linked to an increased risk of ds. Rare ds.
  • 11. CASE-CONTROL STUDIES BASED INA DEFINED COHORT Defined Initial Data &/or Sr.,Urine or Cohort Other specimens YEARS Develop Disease Have Not developed disease Sub-gr CASES selected as CONTROL
  • 12.  Nested Case-Control Studies: -controls are a sample of individuals who are at risk for the ds at the time of each case of the ds develops. -cases & controls are matched on calendar time & length of follow-up. Case-Cohort Studies: -controls are randomly chosen. -Adv: possible to study different diseases.
  • 13. ADVANTAGES OF EMBEDDING ACASE-CONTROL STUDY IN ADEFINED COHORT Recall bias-eliminated. Abnormalities in biologic characteristics like lab values –risk factors. More economical. Less lab burden. Greater comparability b/w cases & controls.
  • 14. MEASUREMENT OF EXPOSURE( IN PRICESLY THE SAME MANNER BOTH FOR CASES & CONTROLS .) Interviews Questionnaires Past records of cases -hospital records -employment records etc.
  • 15. ANALYSIS Exposure rates among cases & controls to suspected factor. Estimation of ds risk asso. With exposure( ODDS RATIO).
  • 16. EXPOSURE RATES: Direct estimation. A Case-Control Study of Smoking &Lung cancer. Cases Controls (with Lung cancer) (without lung cancer)Smokers(<5 cigarettes/d) 33 (a) 55 (b)Non-smokers 2 (c) 27 (d)Total 35 (a+c) 82 (b+d) Exposure rates: . Cases= a/a+c= 33/35 =94.2% . Controls= b/b+d =55/82 =67%.
  • 17. ODDS RATIO(RELATIVE ODDS/ CROSS-PRODUCTS RATIO.) A measure of the Strength of the association b/w risk factor & ds. Def: OR= Odds that a case was exposed Odds that a control was exposed = a/c = b/d ad bc = Product of 2 cells that SUPPORT the hypothesis Product of 2 cells that NEGATE the hypothesis
  • 18.  Interpretation: OR=1 (exposure is not related to the ds) >1 (+ly related) <1 (- ly related). OR is a good approximation of RR when: -cases studied are representative of those with the ds. -controls studied are representative of those without the ds. -ds being studied does not occur frequently.
  • 19.  CALCULATING ‘OR’ IN AN UNMATCHED CASE- CONTROL STUDY: OR= ad bc CALCULATING ‘OR’ IN A MATCHED PAIRS CASE- CONTROL STUDY: CONTROL Exposed Not exposed C Exposed p q A S Not exposed r s E OR=Ratio of discordant pairs=q/r.
  • 20. BIAS Bias due to confounding. Recall bias. Selection bias. Berkesonian bias. Interviewer’s bias.
  • 21. ADVANTAGES Relatively easy. Rapid & inexpensive. Rare ds. No risk to subjects. Allows study of several different aetiological factors. Risk factors can be identified----- rational prevention & control programme No attrition problems. Minimal ethical problem.
  • 22. DISVANTAGES Recall bias. Selection of appropriate control gr. –may be difficult. Cannot measure incidence. Cannot distinguish b/w causes & asso. Factors. Not suited to evaluation of Tt/ Px of ds. Concern about representativeness of cases & controls.
  • 23. EXAMPLES MATERNAL DES THERAPY & ADENOCARCINOMA OF VAGINA IN FEMALE OFFSPRINGS: CASES CONTROLS SIGNIFICANCE (8) (32) LEVELMaternal age 26.1 29.3 n.s.Maternal smoking 7 21 n.s.Antenatal radiology 1 4 n.s.Oestrogen exposure 7 -- P< 0.00001
  • 24. OCP & THROMBOEMBOLIC DISEASE: CASES(Venous CONTROLS thrombosis & pul.embolism) (84) (168)% who used OCP 50 14THALIDOMIDE TRAGEDY: CASES(46) CONTROLS(300)Thalidomide exposure in 41 --early pregnancy
  • 25. REFERENCES Leon Gordis,4th ed. Silman, Macfarane ,2nd ed. Park,20th ed.
  • 26. THANK YOU.